COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
17/01/2025
Bagsværd, Denmark, 17 January 2025 – Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial investigating subcutaneous [...]
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/01/2025
BEDFORD, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has [...]
Enovis™ Announces Leadership Change to International Surgical Business
17/01/2025
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin Reinmann as [...]
Immuron Travelan® continued strong sales growth
17/01/2025
Sales Highlights: Global December 2024 Quarter AUD$2.5 million up 70% on prior quarter, up 249% on pcp December 2024 Half Year AUD$4.0 million up 70% on pcp Australia December 2024 Quarter AUD$1.9 million up 83% on [...]
Junshi Biosciences Announces Toripalimab’s Approval in Australia
17/01/2025
SHANGHAI, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
Digbi Health Expands its Multi-Condition Care Platform to Enhance Efficacy and Adherence to GLP-1 Drugs
17/01/2025
The industry-leading, Precision Biology-based GLP-1 digital companion program Digbi Care (™) gets even better by incorporating continuous glucose monitor, additional gut microbiome, and genetic traits to personalize [...]
ProstaVive: Introducing ProstaVive as the New Standard of Prostate Support in 2025
17/01/2025
TALLMADGE, Ohio, Jan. 17, 2025 (GLOBE NEWSWIRE) -- ProstaVive stands at the forefront of men’s wellness by combining cutting-edge research with premium, all-natural ingredients to create a singular, once-daily formula. [...]
IBA announces Chief Financial Officer transition
17/01/2025
Louvain-La-Neuve, Belgium, January 17, 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the [...]
IBA annonce une transition dans sa direction financière
17/01/2025
Louvain-La-Neuve, Belgique, le 17 janvier 2025 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial de la technologie des accélérateurs de particules et principal fournisseur de solutions de protonthérapie pour [...]
Foundation for Sarcoidosis Research Warns of Increased Risk of Sarcoidosis from Fire and Smoke Exposure Urging Immediate Action to Prevent Future Health Consequences
17/01/2025
9/11 First Responders Serve as a Warning for the Long-Term Health Effects of Smoke Inhalation and Toxic Exposure CHICAGO, Jan. 16, 2025 (GLOBE NEWSWIRE) -- As devastating wildfires and smoke sweep across California, the [...]
Laguna Treatment Center Pilots Value-Based Care with Magellan Health, Leading the Way for Better Patient Outcomes in Addiction Treatment
16/01/2025
ALISO VIEJO, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Laguna Treatment Center , a leading provider of addiction treatment in Southern California, is participating in an innovative pilot program with Magellan Health , a [...]
Illuccix® Receives European Approval
16/01/2025
MELBOURNE, Australia and LIÈGE, Belgium, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive decision on the [...]
Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs
16/01/2025
These options vest when PRPO stock price is 5x the exercise price NEW HAVEN, Conn., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announced that options granted [...]
ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses
16/01/2025
PORTLAND, Maine, Jan. 16, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
Codexis Appoints Christos Richards to Board of Directors
16/01/2025
REDWOOD CITY, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of [...]
Scorpius Holdings Announces Reverse Stock Split
16/01/2025
DURHAM, N.C., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced [...]
Scilex Holding Company Amends its License Agreement with Romeg Therapeutics, LLC, For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares in Adults
16/01/2025
Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Over 70% of gout patients have comorbid conditions that may [...]
Aledade Launches Policy Institute to Shape Value-Based Care Transformation
16/01/2025
Policy Institute to convene national experts and inform policies that strengthen primary care and drive value-based care adoption nationwide BETHESDA, Md., Jan. 16, 2025 (GLOBE NEWSWIRE) -- To strengthen primary care [...]
Vaxil Bio Proposed Reverse Takeover With Green Date Terminated
16/01/2025
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, Jan. 16, [...]

Pages